Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells

24 Mar 2022

Abstract excerpt

Serving as the metabolic hub of the human body, the liver is a vital organ that performs a variety of important physiological functions. Although known for its regenerative potential, it remains vulnerable to a variety of diseases. Despite decades of research, liver disease remains a leading cause of mortality in the United States with a multibillion-dollar-per-year economic burden. Prior research with model...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Liver physiology and pathology
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35456379
DOI: 10.3390/genes13040573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like CellsPMID 35456379Read ↗

Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseasesSemantic proximity Read ↗

The Use of Human Pluripotent Stem Cells for Modeling Liver Development and DiseaseSemantic proximity Read ↗

Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and ApplicationsSemantic proximity Read ↗

Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapySemantic proximity Read ↗

Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug DiscoverySemantic proximity Read ↗

Modeling human liver organ development and diseases with pluripotent stem cell-derived organoidsSemantic proximity Read ↗

The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a ReviewSemantic proximity Read ↗

The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver DiseasesSemantic proximity Read ↗

Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screenSemantic proximity Read ↗

Liver organoids: established tools for disease modeling and drug developmentSemantic proximity Read ↗

Next-Generation Liver Medicine Using Organoid ModelsSemantic proximity Read ↗

Pluripotent Stem Cell–Derived Hepatocytes: Potential and Challenges in PharmacologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.